{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:05:42Z","timestamp":1791396342373,"version":"4.3.3"},"reference-count":70,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A number of DNA repair proteins also play roles in telomere metabolism. To investigate whether the accelerated telomere shortening reported in Fanconi anemia (FA) hematopoietic cells relates to a direct role of the FA pathway in telomere maintenance, we have analyzed telomere dynamics in Fancg-deficient mouse and human cells. We show here that both hematopoietic (stem and differentiated bone marrow cells, B and T lymphocytes) and nonhematopoietic (germ cells, mouse embryonic fibroblasts [MEFs]) Fancg-\/- mouse cells display normal telomere length, normal telomerase activity, and normal chromosome end-capping, even in the presence of extensive clastogen-induced cytogenetic instability (mitomycin C [MMC], gamma-radiation). In addition, telomerase-deficient MEFs with humanlike telomere length and decreased Fancg expression (G5 Terc-\/-\/Fancg shRNA3 MEFs) display normal telomere maintenance. Finally, early-passage primary fibroblasts from patients with FA of complementation group G as well as primary human cells with reduced FANCG expression (FANCG shRNA IMR90 cells) show no signs of telomere dysfunction. Our observations indicate that accelerated telomere shortening in patients with FA is not due to a role of FANCG at telomeres but instead may be secondary to the disease. These findings suggest that telomerase-based therapies could be useful prophylactic agents in FA aplastic anemia by preserving their telomere reserve in the context of the disease. (Blood. 2004;104:3927-3935)<\/jats:p>","DOI":"10.1182\/blood-2003-10-3626","type":"journal-article","created":{"date-parts":[[2004,8,20]],"date-time":"2004-08-20T03:02:35Z","timestamp":1092970955000},"page":"3927-3935","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":25,"title":["Telomere dynamics in Fancg-deficient mouse and human cells"],"prefix":"10.1182","volume":"104","author":[{"given":"Sonia","family":"Franco","sequence":"first","affiliation":[{"name":"From the Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain; Department of Clinical Genetics and Human Genetics, VU University Medical Center, Amsterdam, The Netherlands; and Department of Immunology and Oncology (DIO), National Center of Biotechnology (CNBCSIC), Campus de Cantoblanco, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri J.","family":"van de Vrugt","sequence":"additional","affiliation":[{"name":"From the Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain; Department of Clinical Genetics and Human Genetics, VU University Medical Center, Amsterdam, The Netherlands; and Department of Immunology and Oncology (DIO), National Center of Biotechnology (CNBCSIC), Campus de Cantoblanco, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piedad","family":"Ferna\u0301ndez","sequence":"additional","affiliation":[{"name":"From the Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain; Department of Clinical Genetics and Human Genetics, VU University Medical Center, Amsterdam, The Netherlands; and Department of Immunology and Oncology (DIO), National Center of Biotechnology (CNBCSIC), Campus de Cantoblanco, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Aracil","sequence":"additional","affiliation":[{"name":"From the Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain; Department of Clinical Genetics and Human Genetics, VU University Medical Center, Amsterdam, The Netherlands; and Department of Immunology and Oncology (DIO), National Center of Biotechnology (CNBCSIC), Campus de Cantoblanco, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fre","family":"Arwert","sequence":"additional","affiliation":[{"name":"From the Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain; Department of Clinical Genetics and Human Genetics, VU University Medical Center, Amsterdam, The Netherlands; and Department of Immunology and Oncology (DIO), National Center of Biotechnology (CNBCSIC), Campus de Cantoblanco, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u0301a A.","family":"Blasco","sequence":"additional","affiliation":[{"name":"From the Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain; Department of Clinical Genetics and Human Genetics, VU University Medical Center, Amsterdam, The Netherlands; and Department of Immunology and Oncology (DIO), National Center of Biotechnology (CNBCSIC), Campus de Cantoblanco, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218190893100_REF1","doi-asserted-by":"crossref","unstructured":"Blackburn EH. Switching and signalling at the telomere. Cell.2001;106: 661-673.","DOI":"10.1016\/S0092-8674(01)00492-5"},{"key":"2020021218190893100_REF2","doi-asserted-by":"crossref","unstructured":"de Lange T. Protection of mammalian telomeres. Oncogene.2002;21: 532-540.","DOI":"10.1038\/sj.onc.1205080"},{"key":"2020021218190893100_REF3","doi-asserted-by":"crossref","unstructured":"Bailey SM, Meyne J, Chen DJ, et al. DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc Natl Acad Sci U S A.1999;96: 14899-14904.","DOI":"10.1073\/pnas.96.26.14899"},{"key":"2020021218190893100_REF4","doi-asserted-by":"crossref","unstructured":"Hsu H-L, Gilley D, Galande SA, et al. Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev.2000;14: 2807-2812.","DOI":"10.1101\/gad.844000"},{"key":"2020021218190893100_REF5","doi-asserted-by":"crossref","unstructured":"Samper E, Goytisolo F, Slijepcevic P, van Buul P, Blasco MA. Mammalian Ku86 prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep.2000;1: 244-252.","DOI":"10.1093\/embo-reports\/kvd051"},{"key":"2020021218190893100_REF6","doi-asserted-by":"crossref","unstructured":"Goytisolo F, Samper E, Edmonson S, Taccioli GE, Blasco MA. Absence of DNA-PKcs in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol Cell Biol.2001;21: 3642-3651.","DOI":"10.1128\/MCB.21.11.3642-3651.2001"},{"key":"2020021218190893100_REF7","doi-asserted-by":"crossref","unstructured":"d'Adda di Fagagna F, Hande MP, Tong WM, et al. Effects of DNA non-homologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr Biol.2001;11: 1192-1196.","DOI":"10.1016\/S0960-9822(01)00328-1"},{"key":"2020021218190893100_REF8","doi-asserted-by":"crossref","unstructured":"Espejel S, Franco, S., Rodri\u0301guez-Perales, et al. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J.2002;21: 2207-2219.","DOI":"10.1093\/emboj\/21.9.2207"},{"key":"2020021218190893100_REF9","doi-asserted-by":"crossref","unstructured":"Espejel S, Franco S, Sgura A, et al. Functional interaction between DNA-PKcs and telomerase in telomere length maintenance. EMBO J.2002;21: 6275-6287.","DOI":"10.1093\/emboj\/cdf593"},{"key":"2020021218190893100_REF10","doi-asserted-by":"crossref","unstructured":"Jaco I, Mun\u0303oz P, Goytisolo F, et al. Role of mammalian Rad54 in telomere length maintenance. Mol Cell Biol.2003;23: 5572-5580.","DOI":"10.1128\/MCB.23.16.5572-5580.2003"},{"key":"2020021218190893100_REF11","doi-asserted-by":"crossref","unstructured":"Tarsounas M, Mun\u0303oz P, Claas A, et al. Telomere maintenance requires the RAD51D recombination\/repair protein. Cell.2004;117: 337-347.","DOI":"10.1016\/S0092-8674(04)00337-X"},{"key":"2020021218190893100_REF12","doi-asserted-by":"crossref","unstructured":"Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell.1985;43: 405-413.","DOI":"10.1016\/0092-8674(85)90170-9"},{"key":"2020021218190893100_REF13","doi-asserted-by":"crossref","unstructured":"Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A.1995;92: 9082-9086.","DOI":"10.1073\/pnas.92.20.9082"},{"key":"2020021218190893100_REF14","doi-asserted-by":"crossref","unstructured":"Mitchell JR, Wood E, Collins K. A telomerase component is defective in human disease dyskeratosis congenita. Nature.1999;402: 551-555.","DOI":"10.1038\/990141"},{"key":"2020021218190893100_REF15","doi-asserted-by":"crossref","unstructured":"Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature.2001;413: 432-434.","DOI":"10.1038\/35096585"},{"key":"2020021218190893100_REF16","doi-asserted-by":"crossref","unstructured":"Samper E, Fernandez P, Eguia R, et al. Longterm repopulating ability of telomerase-deficient murine hematopoietic cells. Blood.2002;99: 2767-2775.","DOI":"10.1182\/blood.V99.8.2767"},{"key":"2020021218190893100_REF17","doi-asserted-by":"crossref","unstructured":"Allsop RC, Morin GB, DePinho R, Harley CB, Weissman IL. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood.2003;102: 517-520.","DOI":"10.1182\/blood-2002-07-2334"},{"key":"2020021218190893100_REF18","doi-asserted-by":"crossref","unstructured":"Ball SE, Gibson FM, Rizzo S, et al. Progressive telomere shortening in aplastic anemia. Blood.1998;91: 3582-3592.","DOI":"10.1182\/blood.V91.10.3582"},{"key":"2020021218190893100_REF19","doi-asserted-by":"crossref","unstructured":"Bru\u0308mmendorf T, Maciejewski JP, Mak J, Young NS, Lansdorp PM. Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood.2001;15: 895-900.","DOI":"10.1182\/blood.V97.4.895"},{"key":"2020021218190893100_REF20","doi-asserted-by":"crossref","unstructured":"Baerlocher GM, Ro\u0308th A, Lansdorp PM. Telomeres in hematopoietic cells. Ann N Y Acad Sci.2003;996: 44-48.","DOI":"10.1111\/j.1749-6632.2003.tb03231.x"},{"key":"2020021218190893100_REF21","doi-asserted-by":"crossref","unstructured":"D'Andrea AD, Grompe M. The Fanconi anaemia\/BRCA pathway. Nat Rev Cancer.2003;3: 23-34.","DOI":"10.1038\/nrc970"},{"key":"2020021218190893100_REF22","doi-asserted-by":"crossref","unstructured":"Rothfuss A, Grompe M. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia\/BRCA pathway. Mol Cell Biol.2004;24: 123-134.","DOI":"10.1128\/MCB.24.1.123-134.2004"},{"key":"2020021218190893100_REF23","doi-asserted-by":"crossref","unstructured":"Venkitaraman AR. Tracing the network connecting BRCA and Fanconi anaemia proteins. Nat Rev Cancer.2004;4: 266-276.","DOI":"10.1038\/nrc1321"},{"key":"2020021218190893100_REF24","doi-asserted-by":"crossref","unstructured":"Leteurtre F, Li X, Guardiola P, et al. Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br J Haematol.1999;105: 883-893.","DOI":"10.1046\/j.1365-2141.1999.01445.x"},{"key":"2020021218190893100_REF25","doi-asserted-by":"crossref","unstructured":"Hanson H, Mathew CG, Docherty Z, et al. Telomere shortening in Fanconi anemia demonstrated by a direct approach. Cytogenet Cell Genet.2001;93: 203-206.","DOI":"10.1159\/000056985"},{"key":"2020021218190893100_REF26","doi-asserted-by":"crossref","unstructured":"Adelfalk C, Lorenz M, Serra V, et al. Accelerated telomere shortening in Fanconi anemia fibroblasts - a longitudinal study. FEBS Lett.2001;506: 22-26.","DOI":"10.1016\/S0014-5793(01)02869-1"},{"key":"2020021218190893100_REF27","doi-asserted-by":"crossref","unstructured":"Callen E, Samper E, Ramirez MJ, et al. Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia. Hum Mol Genet.2002;11: 439-444.","DOI":"10.1093\/hmg\/11.4.439"},{"key":"2020021218190893100_REF28","doi-asserted-by":"crossref","unstructured":"Li X, Leteurtre F, Rocha V, Guardiola P, et al. Abnormal telomere metabolism in Fanconi's anemia correlates with genomic instability and the probability of developing severe aplastic anemia. Br J Hematol.2003;120: 836-845.","DOI":"10.1046\/j.1365-2141.2003.04225.x"},{"key":"2020021218190893100_REF29","doi-asserted-by":"crossref","unstructured":"de Winter JP, Waisfisz Q, Rooimans MA, et al. The fanconi anemia group G gene FANCG is identical with XRCC9. Nat Genet.1998;20: 281-283.","DOI":"10.1038\/3093"},{"key":"2020021218190893100_REF30","doi-asserted-by":"crossref","unstructured":"Blom E, van de Vrugt HJ, de Winter JP, Arwert F, Joenje H. Multiple TPR motifs characterize the Fanconi anemia FANCG protein. DNA Repair.2004;3: 77-84.","DOI":"10.1016\/j.dnarep.2003.09.007"},{"key":"2020021218190893100_REF31","doi-asserted-by":"crossref","unstructured":"Hussain S, Witt E, Huber PA, Medhurst AL, Ashworth A, Mathew CG. Direct interaction of the Fanconi anemia protein FANCG with BRCA2\/FANCD1. Hum Mol Genet.2003;12: 2503-2510.","DOI":"10.1093\/hmg\/ddg266"},{"key":"2020021218190893100_REF32","doi-asserted-by":"crossref","unstructured":"Koomen M, Cheng NC, van de Vrugt HJ, et al. Reduced fertility and hypersensitivity to mitomycin C characterize Fancg\/Xrcc9 null mice. Hum Mol Genet.2002;11: 273-281.","DOI":"10.1093\/hmg\/11.3.273"},{"key":"2020021218190893100_REF33","doi-asserted-by":"crossref","unstructured":"van de Vrugt HJ, Koomen M, Berns MA, et al. Characterization, expression and complex formation of the murine Fanconi anaemia gene product Fancg. Genes Cells.2002;7: 333-342.","DOI":"10.1046\/j.1365-2443.2002.00518.x"},{"key":"2020021218190893100_REF34","doi-asserted-by":"crossref","unstructured":"Blasco MA, Lee HW, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell.1997;91: 1-3.","DOI":"10.1016\/S0092-8674(01)80006-4"},{"key":"2020021218190893100_REF35","doi-asserted-by":"crossref","unstructured":"Herbig U, Jobling WA, Chen PBC, Chen DJ, Sedivy JM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, p21CIP1, but not p16 INK4a. Mol Cell.2004; 501-513.","DOI":"10.1016\/S1097-2765(04)00256-4"},{"key":"2020021218190893100_REF36","doi-asserted-by":"crossref","unstructured":"Rufer N, Dragowska W, Thornbury G, et al. Telomere dynamics in lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol.1998;16: 743-747.","DOI":"10.1038\/nbt0898-743"},{"key":"2020021218190893100_REF37","unstructured":"McIlrath J, Bouffler SD, Samper E, et al. Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res.2001;61: 912-915."},{"key":"2020021218190893100_REF38","doi-asserted-by":"crossref","unstructured":"Kipling D, Cooke HJ. Hypervariable ultra-long telomeres in mice. Nature.1990;347: 400-402.","DOI":"10.1038\/347400a0"},{"key":"2020021218190893100_REF39","doi-asserted-by":"crossref","unstructured":"Hande MP, Samper E, Lansdorp P, Blasco MA. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol.1999;144: 589-601.","DOI":"10.1083\/jcb.144.4.589"},{"key":"2020021218190893100_REF40","doi-asserted-by":"crossref","unstructured":"Yang Y, Kuang Y, De Oca RM, et al. Targeted disruption of the murine Fanconi anemia gene, Fancg\/Xrcc9. Blood.2001;98: 3435-3440.","DOI":"10.1182\/blood.V98.12.3435"},{"key":"2020021218190893100_REF41","doi-asserted-by":"crossref","unstructured":"Blasco MA, Rizen M, Greider CW, Hanahan D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet.1996;12: 200-204.","DOI":"10.1038\/ng0296-200"},{"key":"2020021218190893100_REF42","doi-asserted-by":"crossref","unstructured":"Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interference RNAs in mammalian cells. Science.2002;296: 550-553.","DOI":"10.1126\/science.1068999"},{"key":"2020021218190893100_REF43","doi-asserted-by":"crossref","unstructured":"Goytisolo F, Blasco MA. Many ways to telomere dysfunction: in vivo studies using mouse models. Oncogene.2002;21: 584-591.","DOI":"10.1038\/sj.onc.1205085"},{"key":"2020021218190893100_REF44","doi-asserted-by":"crossref","unstructured":"Latre L, Tusell L, Martin M, et al. Shortened telomeres join to DNA breaks interfering with their correct repair. Exp Cell Res.2003;287: 282-288.","DOI":"10.1016\/S0014-4827(03)00134-4"},{"key":"2020021218190893100_REF45","doi-asserted-by":"crossref","unstructured":"Collins K, Mitchell JR. Telomerase in the human organism. Oncogene.2002;21: 564-579.","DOI":"10.1038\/sj.onc.1205083"},{"key":"2020021218190893100_REF46","doi-asserted-by":"crossref","unstructured":"Henson JD, Neumann AA, Yeager TR, Reddel RR. Alternative lengthening of telomeres in mammalian cells. Oncogene.2002;21: 598-610.","DOI":"10.1038\/sj.onc.1205058"},{"key":"2020021218190893100_REF47","doi-asserted-by":"crossref","unstructured":"Yamamoto K, Ishiai M, Matsushita N, et al. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double strand breaks by homologous recombination in vertebrate cells. Mol Cell Biol.2003;23: 5421-5430.","DOI":"10.1128\/MCB.23.15.5421-5430.2003"},{"key":"2020021218190893100_REF48","unstructured":"Aube\u0301 M, Lafrance M, Brodeur I, Delisle M-C, Carreau M. Fanconi anemia genes are highly expressed in primitive CD34+ hematopoietic cells. BMC Blood Disord.2003;3: 1-9."},{"key":"2020021218190893100_REF49","doi-asserted-by":"crossref","unstructured":"Carreau M, Gan OI, Liu L, Doedens M, Dick JE, Buchwald M. Hematopoietic compartment of Fanconi anemia group C null mice contains fewer lineage-negative CD34+ primitive hematopoietic cells and shows reduced reconstruction ability. Exp Hematol.1999;27: 1667-1674.","DOI":"10.1016\/S0301-472X(99)00102-2"},{"key":"2020021218190893100_REF50","doi-asserted-by":"crossref","unstructured":"Haneline LS, Gobbett TA, Ramani R, et al. Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. Blood.1999;94: 1-8.","DOI":"10.1182\/blood.V94.1.1.413k03_1_8"},{"key":"2020021218190893100_REF51","doi-asserted-by":"crossref","unstructured":"Li X, Plett PA, Yang Y, et al. Fanconi anemia type C deficient hematopoietic stem\/progenitor cells exhibit aberrant cell cycle control. Blood.2003;102: 2081-2084.","DOI":"10.1182\/blood-2003-02-0536"},{"key":"2020021218190893100_REF52","doi-asserted-by":"crossref","unstructured":"Hadjur S, Jirik FR. Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines. Blood.2003;101: 3877-3884.","DOI":"10.1182\/blood-2002-10-3147"},{"key":"2020021218190893100_REF53","doi-asserted-by":"crossref","unstructured":"Allsop RC, Cheshier S, Weissman IL. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J Exp Med.2001;193: 917-924.","DOI":"10.1084\/jem.193.8.917"},{"key":"2020021218190893100_REF54","doi-asserted-by":"crossref","unstructured":"Hemann MT, Strong MA, Hao LY, Greider CW. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell.2001;107: 67-77.","DOI":"10.1016\/S0092-8674(01)00504-9"},{"key":"2020021218190893100_REF55","doi-asserted-by":"crossref","unstructured":"Samper E, Flores JM, Blasco MA. Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc-\/- mice with short telomeres. EMBO Rep.2001;2: 800-807.","DOI":"10.1093\/embo-reports\/kve174"},{"key":"2020021218190893100_REF56","doi-asserted-by":"crossref","unstructured":"Wong JC, Alon N, Mckerlie C, Huang JR, Meyn MS, Buchwald M. Targeted disruption of exons 1 to 6 of the Fanconi anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. Hum Mol Genet.2003;12: 2063-2076.","DOI":"10.1093\/hmg\/ddg219"},{"key":"2020021218190893100_REF57","doi-asserted-by":"crossref","unstructured":"Houghtaling S, Timmers C, Noll M, et al. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev.2003;17: 2021-2035.","DOI":"10.1101\/gad.1103403"},{"key":"2020021218190893100_REF58","doi-asserted-by":"crossref","unstructured":"Hemann MT, Rudolph KL, Strong MA, De Pinho RA, Chin L, Greider CW. Telomere dysfunction triggers developmentally regulated germ cell apoptosis. Mol Biol Cell.2001;12: 2023-2030.","DOI":"10.1091\/mbc.12.7.2023"},{"key":"2020021218190893100_REF59","doi-asserted-by":"crossref","unstructured":"Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A.1992;89: 10114-10118.","DOI":"10.1073\/pnas.89.21.10114"},{"key":"2020021218190893100_REF60","doi-asserted-by":"crossref","unstructured":"Martens UM, Chavez EA, Poon SS, Schmoor C, Lansdorp PM. Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp Cell Res.2000;256: 291-299.","DOI":"10.1006\/excr.2000.4823"},{"key":"2020021218190893100_REF61","doi-asserted-by":"crossref","unstructured":"Ohyashiki JH, Sashida G, Tauchi T, Ohyashiki K. Telomeres and telomerase in hematological neoplasia. Oncogene.2002;21: 680-687.","DOI":"10.1038\/sj.onc.1205075"},{"key":"2020021218190893100_REF62","doi-asserted-by":"crossref","unstructured":"Marciniak R, Guarente L. Testing telomerase. Nature.2001;413: 370-372.","DOI":"10.1038\/35096663"},{"key":"2020021218190893100_REF63","doi-asserted-by":"crossref","unstructured":"Wolthers KC, Bea G, Wisman A, et al. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science.1996;274: 1543-1547.","DOI":"10.1126\/science.274.5292.1543"},{"key":"2020021218190893100_REF64","doi-asserted-by":"crossref","unstructured":"Notaro R, Cimmino A, Tabarini D, Luzzatto L. In vivo telomere dynamics of human hematopoietc cells. Proc Natl Acad Sci U S A.1997;94: 13782-13785.","DOI":"10.1073\/pnas.94.25.13782"},{"key":"2020021218190893100_REF65","doi-asserted-by":"crossref","unstructured":"Pagano G, Youssoufian H. Fanconi anemia proteins: major roles in cell protection against oxidative damage. BioEssays.2003;25: 589-595.","DOI":"10.1002\/bies.10283"},{"key":"2020021218190893100_REF66","doi-asserted-by":"crossref","unstructured":"Park S-J, Ciccone SLM, Beck BD, et al. Oxidative stress\/damage induces multimerization and interaction of Fanconi anemia proteins. J Biol Chem.2004;279: 30053-30059.","DOI":"10.1074\/jbc.M403527200"},{"key":"2020021218190893100_REF67","doi-asserted-by":"crossref","unstructured":"von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci.2002;27: 339-344.","DOI":"10.1016\/S0968-0004(02)02110-2"},{"key":"2020021218190893100_REF68","doi-asserted-by":"crossref","unstructured":"Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell.2001;7: 249-262.","DOI":"10.1016\/S1097-2765(01)00173-3"},{"key":"2020021218190893100_REF69","doi-asserted-by":"crossref","unstructured":"Hirsch B, Shimamura A, Moreau L, et al. Association of biallelic BRCA2\/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood.2004;103: 2554-2559.","DOI":"10.1182\/blood-2003-06-1970"},{"key":"2020021218190893100_REF70","doi-asserted-by":"crossref","unstructured":"Lensch MW, Tishkowitz M, Christianson TA, et al. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia. Blood.2003;102: 7-16.","DOI":"10.1182\/blood-2002-09-2781"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/13\/3927\/1704225\/zh802404003927.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/13\/3927\/1704225\/zh802404003927.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:27:12Z","timestamp":1581553632000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/13\/3927\/18977\/Telomere-dynamics-in-Fancgdeficient-mouse-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,15]]},"references-count":70,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2004,12,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-10-3626","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,15]]}}}